Identifying the Neural Signature of Exercise to Advance Treatment of PD Cognitive Declines

Description

Twenty-five participants with PD utilizing the Medtronic Percept PC DBS system will be enrolled for this project and complete a single bout of both FE and VE. The 150-minute experimental session will be completed in the OFF antiparkinsonian and Off-DBS state.

Conditions

Parkinson Disease

Study Overview

Study Details

Study overview

Twenty-five participants with PD utilizing the Medtronic Percept PC DBS system will be enrolled for this project and complete a single bout of both FE and VE. The 150-minute experimental session will be completed in the OFF antiparkinsonian and Off-DBS state.

Identifying the Neural Signature of Exercise to Advance Treatment of PD Cognitive Declines

Identifying the Neural Signature of Exercise to Advance Treatment of PD Cognitive Declines

Condition
Parkinson Disease
Intervention / Treatment

-

Contacts and Locations

Cleveland

Cleveland Clinic, Cleveland, Ohio, United States, 44195

Cleveland

Cleveland Clinic, Cleveland, Ohio, United States, 44195

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Adult with a diagnosis of PD by a movement disorders neurologist
  • * Previous placement, at least six months, of bilateral Medtronic Precept DBS as standard of care treatment for their PD.
  • * Stable and clinically optimized DBS parameters for three months prior to enrollment.
  • * Demonstrate the ability to safely mount and dismount a recumbent exercise cycle with an upright back.
  • * Willingness to withhold antiparkinsonian medication and DBS stimulation.
  • * Exercise clearance using the American College of Sports Medicine (ACSM) Pre-participation Health Screen: a. If the ACSM screen recommends medical clearance, the subject must obtain medical clearance by their health care provider prior to participation; b. Those who choose not to obtain physician clearance will not be eligible for participation.
  • * Diagnosis of dementia or any neurocognitive impairment that compromises the ability to provide informed consent.
  • * A musculoskeletal issue that limits one's ability to cycle
  • * Neurological disease other than Parkinson's disease (i.e. multiple sclerosis, stroke) that impacts motor or cognitive function
  • * Uncontrolled cardiovascular risk factor such as a current cardiac arrhythmia, uncontrolled hypertension, untreated deep vein thrombosis, etc.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

The Cleveland Clinic,

Study Record Dates

2025-12-31